nodes	percent_of_prediction	percent_of_DWPC	metapath
Sibutramine—CYP3A4—Felbamate Metabolism—CYP2E1—liver cancer	0.00516	0.0467	CbGpPWpGaD
Sibutramine—CYP3A4—Liver X Receptor Pathway—SCD—liver cancer	0.0031	0.0281	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—DNAJB1—liver cancer	0.00225	0.0203	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—SIX3—liver cancer	0.00205	0.0185	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—DNAJB1—liver cancer	0.00193	0.0175	CbGpPWpGaD
Sibutramine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A2—liver cancer	0.00181	0.0164	CbGpPWpGaD
Sibutramine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC40A1—liver cancer	0.00173	0.0156	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—DNAJB1—liver cancer	0.00171	0.0155	CbGpPWpGaD
Sibutramine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1H4—liver cancer	0.00171	0.0155	CbGpPWpGaD
Sibutramine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—liver cancer	0.00168	0.0152	CbGpPWpGaD
Sibutramine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A2—liver cancer	0.0016	0.0145	CbGpPWpGaD
Sibutramine—CYP3A4—Farnesoid X Receptor  Pathway—NR1H4—liver cancer	0.00156	0.0142	CbGpPWpGaD
Sibutramine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC40A1—liver cancer	0.00153	0.0138	CbGpPWpGaD
Sibutramine—SLC6A3—Parkinsons Disease Pathway—CYCS—liver cancer	0.0015	0.0135	CbGpPWpGaD
Sibutramine—SLC6A4—Monoamine Transport—MAPK14—liver cancer	0.00146	0.0132	CbGpPWpGaD
Sibutramine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—liver cancer	0.00144	0.013	CbGpPWpGaD
Sibutramine—CYP3A4—Estrogen metabolism—GSTA1—liver cancer	0.00138	0.0125	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—GSTA3—liver cancer	0.00129	0.0117	CbGpPWpGaD
Sibutramine—SLC6A2—Monoamine Transport—MAPK14—liver cancer	0.00126	0.0114	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—GSTA4—liver cancer	0.00118	0.0107	CbGpPWpGaD
Sibutramine—Increased appetite—Doxorubicin—liver cancer	0.00116	0.00131	CcSEcCtD
Sibutramine—Affect lability—Epirubicin—liver cancer	0.00116	0.00131	CcSEcCtD
Sibutramine—Migraine—Epirubicin—liver cancer	0.00116	0.00131	CcSEcCtD
Sibutramine—Hypersensitivity—Sorafenib—liver cancer	0.00116	0.0013	CcSEcCtD
Sibutramine—SLC6A4—NRF2 pathway—GSTA2—liver cancer	0.00115	0.0104	CbGpPWpGaD
Sibutramine—Renal impairment—Doxorubicin—liver cancer	0.00115	0.00129	CcSEcCtD
Sibutramine—Dermatitis bullous—Doxorubicin—liver cancer	0.00114	0.00129	CcSEcCtD
Sibutramine—Face oedema—Epirubicin—liver cancer	0.00114	0.00128	CcSEcCtD
Sibutramine—Purpura—Doxorubicin—liver cancer	0.00113	0.00128	CcSEcCtD
Sibutramine—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00113	0.00127	CcSEcCtD
Sibutramine—Asthenia—Sorafenib—liver cancer	0.00113	0.00127	CcSEcCtD
Sibutramine—Cardiac arrest—Epirubicin—liver cancer	0.00112	0.00126	CcSEcCtD
Sibutramine—Hypoglycaemia—Doxorubicin—liver cancer	0.00112	0.00126	CcSEcCtD
Sibutramine—Mood swings—Epirubicin—liver cancer	0.00112	0.00126	CcSEcCtD
Sibutramine—Cerebrovascular accident—Doxorubicin—liver cancer	0.00112	0.00125	CcSEcCtD
Sibutramine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—liver cancer	0.00111	0.0101	CbGpPWpGaD
Sibutramine—SLC6A3—Monoamine Transport—MAPK14—liver cancer	0.00111	0.0101	CbGpPWpGaD
Sibutramine—Pruritus—Sorafenib—liver cancer	0.00111	0.00125	CcSEcCtD
Sibutramine—Ataxia—Epirubicin—liver cancer	0.00111	0.00125	CcSEcCtD
Sibutramine—SLC6A4—NRF2 pathway—GSTA1—liver cancer	0.00111	0.01	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—GSTA3—liver cancer	0.00111	0.01	CbGpPWpGaD
Sibutramine—Blood creatinine increased—Epirubicin—liver cancer	0.00111	0.00124	CcSEcCtD
Sibutramine—Dehydration—Epirubicin—liver cancer	0.0011	0.00124	CcSEcCtD
Sibutramine—Pain in extremity—Doxorubicin—liver cancer	0.00109	0.00123	CcSEcCtD
Sibutramine—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00109	0.00123	CcSEcCtD
Sibutramine—Osteoarthritis—Doxorubicin—liver cancer	0.00109	0.00123	CcSEcCtD
Sibutramine—Liver function test abnormal—Epirubicin—liver cancer	0.00109	0.00123	CcSEcCtD
Sibutramine—Dry skin—Epirubicin—liver cancer	0.00108	0.00122	CcSEcCtD
Sibutramine—Orthostatic hypotension—Epirubicin—liver cancer	0.00108	0.00121	CcSEcCtD
Sibutramine—Affect lability—Doxorubicin—liver cancer	0.00108	0.00121	CcSEcCtD
Sibutramine—Migraine—Doxorubicin—liver cancer	0.00108	0.00121	CcSEcCtD
Sibutramine—Hypokalaemia—Epirubicin—liver cancer	0.00108	0.00121	CcSEcCtD
Sibutramine—Diarrhoea—Sorafenib—liver cancer	0.00108	0.00121	CcSEcCtD
Sibutramine—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00106	0.0012	CcSEcCtD
Sibutramine—Face oedema—Doxorubicin—liver cancer	0.00106	0.00119	CcSEcCtD
Sibutramine—Gastritis—Epirubicin—liver cancer	0.00105	0.00118	CcSEcCtD
Sibutramine—Muscular weakness—Epirubicin—liver cancer	0.00104	0.00117	CcSEcCtD
Sibutramine—Alanine aminotransferase increased—Epirubicin—liver cancer	0.00104	0.00117	CcSEcCtD
Sibutramine—Cardiac arrest—Doxorubicin—liver cancer	0.00104	0.00117	CcSEcCtD
Sibutramine—Dizziness—Sorafenib—liver cancer	0.00104	0.00117	CcSEcCtD
Sibutramine—Mood swings—Doxorubicin—liver cancer	0.00104	0.00116	CcSEcCtD
Sibutramine—Abdominal distension—Epirubicin—liver cancer	0.00103	0.00116	CcSEcCtD
Sibutramine—Ataxia—Doxorubicin—liver cancer	0.00103	0.00116	CcSEcCtD
Sibutramine—Blood creatinine increased—Doxorubicin—liver cancer	0.00102	0.00115	CcSEcCtD
Sibutramine—Asthma—Epirubicin—liver cancer	0.00102	0.00115	CcSEcCtD
Sibutramine—Influenza—Epirubicin—liver cancer	0.00102	0.00115	CcSEcCtD
Sibutramine—Dysphagia—Epirubicin—liver cancer	0.00102	0.00115	CcSEcCtD
Sibutramine—Dehydration—Doxorubicin—liver cancer	0.00102	0.00114	CcSEcCtD
Sibutramine—SLC6A2—NRF2 pathway—GSTA4—liver cancer	0.00101	0.00918	CbGpPWpGaD
Sibutramine—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—liver cancer	0.00101	0.00918	CbGpPWpGaD
Sibutramine—Eosinophilia—Epirubicin—liver cancer	0.00101	0.00114	CcSEcCtD
Sibutramine—Liver function test abnormal—Doxorubicin—liver cancer	0.00101	0.00114	CcSEcCtD
Sibutramine—Dry skin—Doxorubicin—liver cancer	0.001	0.00113	CcSEcCtD
Sibutramine—Vomiting—Sorafenib—liver cancer	0.000999	0.00112	CcSEcCtD
Sibutramine—Orthostatic hypotension—Doxorubicin—liver cancer	0.000999	0.00112	CcSEcCtD
Sibutramine—Hypokalaemia—Doxorubicin—liver cancer	0.000995	0.00112	CcSEcCtD
Sibutramine—Angina pectoris—Epirubicin—liver cancer	0.000995	0.00112	CcSEcCtD
Sibutramine—Rash—Sorafenib—liver cancer	0.000991	0.00111	CcSEcCtD
Sibutramine—Dermatitis—Sorafenib—liver cancer	0.00099	0.00111	CcSEcCtD
Sibutramine—SLC6A2—NRF2 pathway—GSTA2—liver cancer	0.000989	0.00895	CbGpPWpGaD
Sibutramine—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000985	0.00111	CcSEcCtD
Sibutramine—Headache—Sorafenib—liver cancer	0.000985	0.00111	CcSEcCtD
Sibutramine—SLC6A3—NRF2 pathway—GSTA3—liver cancer	0.000983	0.0089	CbGpPWpGaD
Sibutramine—Bronchitis—Epirubicin—liver cancer	0.000982	0.0011	CcSEcCtD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.000982	0.00889	CbGpPWpGaD
Sibutramine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—liver cancer	0.000978	0.00885	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—NFE2L2—liver cancer	0.000978	0.00885	CbGpPWpGaD
Sibutramine—SLC6A3—Parkinsons Disease Pathway—MAPK14—liver cancer	0.00097	0.00878	CbGpPWpGaD
Sibutramine—Gastritis—Doxorubicin—liver cancer	0.000968	0.00109	CcSEcCtD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.000966	0.00874	CbGpPWpGaD
Sibutramine—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000965	0.00108	CcSEcCtD
Sibutramine—Muscular weakness—Doxorubicin—liver cancer	0.000965	0.00108	CcSEcCtD
Sibutramine—Dysuria—Epirubicin—liver cancer	0.000955	0.00107	CcSEcCtD
Sibutramine—SLC6A2—NRF2 pathway—GSTA1—liver cancer	0.000954	0.00863	CbGpPWpGaD
Sibutramine—Abdominal distension—Doxorubicin—liver cancer	0.000952	0.00107	CcSEcCtD
Sibutramine—Asthma—Doxorubicin—liver cancer	0.000945	0.00106	CcSEcCtD
Sibutramine—Influenza—Doxorubicin—liver cancer	0.000945	0.00106	CcSEcCtD
Sibutramine—Dysphagia—Doxorubicin—liver cancer	0.000945	0.00106	CcSEcCtD
Sibutramine—Pollakiuria—Epirubicin—liver cancer	0.000944	0.00106	CcSEcCtD
Sibutramine—Eosinophilia—Doxorubicin—liver cancer	0.000936	0.00105	CcSEcCtD
Sibutramine—Nausea—Sorafenib—liver cancer	0.000934	0.00105	CcSEcCtD
Sibutramine—SLC6A4—NRF2 pathway—TGFA—liver cancer	0.000933	0.00844	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—GPX3—liver cancer	0.000933	0.00844	CbGpPWpGaD
Sibutramine—Photosensitivity reaction—Epirubicin—liver cancer	0.000932	0.00105	CcSEcCtD
Sibutramine—Weight increased—Epirubicin—liver cancer	0.00093	0.00105	CcSEcCtD
Sibutramine—Hyperglycaemia—Epirubicin—liver cancer	0.000922	0.00104	CcSEcCtD
Sibutramine—Angina pectoris—Doxorubicin—liver cancer	0.000921	0.00104	CcSEcCtD
Sibutramine—SLC6A4—NRF2 pathway—SERPINA1—liver cancer	0.000919	0.00832	CbGpPWpGaD
Sibutramine—Pneumonia—Epirubicin—liver cancer	0.000916	0.00103	CcSEcCtD
Sibutramine—Bronchitis—Doxorubicin—liver cancer	0.000909	0.00102	CcSEcCtD
Sibutramine—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.000903	0.00818	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—GSTA4—liver cancer	0.000899	0.00814	CbGpPWpGaD
Sibutramine—Renal failure—Epirubicin—liver cancer	0.000895	0.00101	CcSEcCtD
Sibutramine—Neuropathy peripheral—Epirubicin—liver cancer	0.000893	0.001	CcSEcCtD
Sibutramine—Stomatitis—Epirubicin—liver cancer	0.000888	0.000998	CcSEcCtD
Sibutramine—Conjunctivitis—Epirubicin—liver cancer	0.000885	0.000995	CcSEcCtD
Sibutramine—Urinary tract infection—Epirubicin—liver cancer	0.000885	0.000995	CcSEcCtD
Sibutramine—Dysuria—Doxorubicin—liver cancer	0.000884	0.000994	CcSEcCtD
Sibutramine—SLC6A3—NRF2 pathway—GSTA2—liver cancer	0.000876	0.00793	CbGpPWpGaD
Sibutramine—Sweating—Epirubicin—liver cancer	0.000873	0.000982	CcSEcCtD
Sibutramine—Pollakiuria—Doxorubicin—liver cancer	0.000873	0.000982	CcSEcCtD
Sibutramine—Haematuria—Epirubicin—liver cancer	0.000868	0.000976	CcSEcCtD
Sibutramine—Photosensitivity reaction—Doxorubicin—liver cancer	0.000863	0.00097	CcSEcCtD
Sibutramine—Weight increased—Doxorubicin—liver cancer	0.00086	0.000967	CcSEcCtD
Sibutramine—Epistaxis—Epirubicin—liver cancer	0.000859	0.000966	CcSEcCtD
Sibutramine—Sinusitis—Epirubicin—liver cancer	0.000855	0.000961	CcSEcCtD
Sibutramine—Hyperglycaemia—Doxorubicin—liver cancer	0.000853	0.000959	CcSEcCtD
Sibutramine—Pneumonia—Doxorubicin—liver cancer	0.000848	0.000953	CcSEcCtD
Sibutramine—SLC6A3—NRF2 pathway—GSTA1—liver cancer	0.000845	0.00765	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—NFE2L2—liver cancer	0.000841	0.00761	CbGpPWpGaD
Sibutramine—Bradycardia—Epirubicin—liver cancer	0.000832	0.000936	CcSEcCtD
Sibutramine—Renal failure—Doxorubicin—liver cancer	0.000828	0.000931	CcSEcCtD
Sibutramine—Neuropathy peripheral—Doxorubicin—liver cancer	0.000826	0.000929	CcSEcCtD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.000822	0.00744	CbGpPWpGaD
Sibutramine—Haemoglobin—Epirubicin—liver cancer	0.000822	0.000924	CcSEcCtD
Sibutramine—Stomatitis—Doxorubicin—liver cancer	0.000822	0.000924	CcSEcCtD
Sibutramine—Rhinitis—Epirubicin—liver cancer	0.00082	0.000922	CcSEcCtD
Sibutramine—Conjunctivitis—Doxorubicin—liver cancer	0.000819	0.000921	CcSEcCtD
Sibutramine—Urinary tract infection—Doxorubicin—liver cancer	0.000819	0.000921	CcSEcCtD
Sibutramine—CYP3A4—Xenobiotics—CYP2E1—liver cancer	0.000818	0.0074	CbGpPWpGaD
Sibutramine—Haemorrhage—Epirubicin—liver cancer	0.000818	0.000919	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—MYO5B—liver cancer	0.000816	0.00739	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.000816	0.00739	CbGpPWpGaD
Sibutramine—Hypoaesthesia—Epirubicin—liver cancer	0.000814	0.000915	CcSEcCtD
Sibutramine—Pharyngitis—Epirubicin—liver cancer	0.000812	0.000912	CcSEcCtD
Sibutramine—Sweating—Doxorubicin—liver cancer	0.000808	0.000908	CcSEcCtD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—GLUL—liver cancer	0.000806	0.00729	CbGpPWpGaD
Sibutramine—Oedema peripheral—Epirubicin—liver cancer	0.000806	0.000906	CcSEcCtD
Sibutramine—Haematuria—Doxorubicin—liver cancer	0.000804	0.000903	CcSEcCtD
Sibutramine—SLC6A2—NRF2 pathway—GPX3—liver cancer	0.000802	0.00726	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—TGFA—liver cancer	0.000802	0.00726	CbGpPWpGaD
Sibutramine—Epistaxis—Doxorubicin—liver cancer	0.000795	0.000894	CcSEcCtD
Sibutramine—Sinusitis—Doxorubicin—liver cancer	0.000791	0.000889	CcSEcCtD
Sibutramine—SLC6A2—NRF2 pathway—SERPINA1—liver cancer	0.00079	0.00715	CbGpPWpGaD
Sibutramine—Visual impairment—Epirubicin—liver cancer	0.000788	0.000886	CcSEcCtD
Sibutramine—CYP3A4—Tamoxifen metabolism—CYP2E1—liver cancer	0.000787	0.00712	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.000784	0.0071	CbGpPWpGaD
Sibutramine—CYP3A4—Aflatoxin activation and detoxification—GGT1—liver cancer	0.000783	0.00708	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—AHR—liver cancer	0.000777	0.00703	CbGpPWpGaD
Sibutramine—Bradycardia—Doxorubicin—liver cancer	0.00077	0.000866	CcSEcCtD
Sibutramine—Eye disorder—Epirubicin—liver cancer	0.000764	0.000859	CcSEcCtD
Sibutramine—Tinnitus—Epirubicin—liver cancer	0.000762	0.000857	CcSEcCtD
Sibutramine—Haemoglobin—Doxorubicin—liver cancer	0.00076	0.000855	CcSEcCtD
Sibutramine—Rhinitis—Doxorubicin—liver cancer	0.000759	0.000853	CcSEcCtD
Sibutramine—Haemorrhage—Doxorubicin—liver cancer	0.000757	0.000851	CcSEcCtD
Sibutramine—Hypoaesthesia—Doxorubicin—liver cancer	0.000753	0.000846	CcSEcCtD
Sibutramine—Pharyngitis—Doxorubicin—liver cancer	0.000751	0.000844	CcSEcCtD
Sibutramine—Oedema peripheral—Doxorubicin—liver cancer	0.000745	0.000838	CcSEcCtD
Sibutramine—SLC6A3—NRF2 pathway—NFE2L2—liver cancer	0.000745	0.00674	CbGpPWpGaD
Sibutramine—Angiopathy—Epirubicin—liver cancer	0.000742	0.000834	CcSEcCtD
Sibutramine—Immune system disorder—Epirubicin—liver cancer	0.000739	0.00083	CcSEcCtD
Sibutramine—Chills—Epirubicin—liver cancer	0.000734	0.000825	CcSEcCtD
Sibutramine—Arrhythmia—Epirubicin—liver cancer	0.00073	0.000821	CcSEcCtD
Sibutramine—Visual impairment—Doxorubicin—liver cancer	0.000729	0.00082	CcSEcCtD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.000728	0.00659	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—MYO5B—liver cancer	0.000723	0.00654	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.000723	0.00654	CbGpPWpGaD
Sibutramine—Alopecia—Epirubicin—liver cancer	0.000723	0.000812	CcSEcCtD
Sibutramine—Malnutrition—Epirubicin—liver cancer	0.000712	0.0008	CcSEcCtD
Sibutramine—SLC6A3—NRF2 pathway—TGFA—liver cancer	0.00071	0.00643	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—GPX3—liver cancer	0.00071	0.00643	CbGpPWpGaD
Sibutramine—Eye disorder—Doxorubicin—liver cancer	0.000707	0.000795	CcSEcCtD
Sibutramine—Tinnitus—Doxorubicin—liver cancer	0.000705	0.000793	CcSEcCtD
Sibutramine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.000703	0.00636	CbGpPWpGaD
Sibutramine—Flatulence—Epirubicin—liver cancer	0.000701	0.000789	CcSEcCtD
Sibutramine—SLC6A3—NRF2 pathway—SERPINA1—liver cancer	0.0007	0.00634	CbGpPWpGaD
Sibutramine—Tension—Epirubicin—liver cancer	0.000699	0.000785	CcSEcCtD
Sibutramine—Dysgeusia—Epirubicin—liver cancer	0.000697	0.000784	CcSEcCtD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.000695	0.00629	CbGpPWpGaD
Sibutramine—SLC6A4—Monoamine Transport—TNF—liver cancer	0.000694	0.00629	CbGpPWpGaD
Sibutramine—Nervousness—Epirubicin—liver cancer	0.000691	0.000777	CcSEcCtD
Sibutramine—Back pain—Epirubicin—liver cancer	0.000689	0.000774	CcSEcCtD
Sibutramine—Angiopathy—Doxorubicin—liver cancer	0.000686	0.000772	CcSEcCtD
Sibutramine—Muscle spasms—Epirubicin—liver cancer	0.000684	0.000769	CcSEcCtD
Sibutramine—Immune system disorder—Doxorubicin—liver cancer	0.000683	0.000768	CcSEcCtD
Sibutramine—Chills—Doxorubicin—liver cancer	0.000679	0.000763	CcSEcCtD
Sibutramine—Arrhythmia—Doxorubicin—liver cancer	0.000676	0.00076	CcSEcCtD
Sibutramine—CYP3A4—Estrogen metabolism—GSTM1—liver cancer	0.000674	0.00611	CbGpPWpGaD
Sibutramine—Vision blurred—Epirubicin—liver cancer	0.000671	0.000754	CcSEcCtD
Sibutramine—Alopecia—Doxorubicin—liver cancer	0.000669	0.000752	CcSEcCtD
Sibutramine—Ill-defined disorder—Epirubicin—liver cancer	0.00066	0.000742	CcSEcCtD
Sibutramine—Malnutrition—Doxorubicin—liver cancer	0.000659	0.00074	CcSEcCtD
Sibutramine—Anaemia—Epirubicin—liver cancer	0.000658	0.00074	CcSEcCtD
Sibutramine—SLC6A4—NRF2 pathway—GGT1—liver cancer	0.000656	0.00594	CbGpPWpGaD
Sibutramine—Agitation—Epirubicin—liver cancer	0.000654	0.000735	CcSEcCtD
Sibutramine—Flatulence—Doxorubicin—liver cancer	0.000649	0.00073	CcSEcCtD
Sibutramine—Tension—Doxorubicin—liver cancer	0.000646	0.000727	CcSEcCtD
Sibutramine—Dysgeusia—Doxorubicin—liver cancer	0.000645	0.000725	CcSEcCtD
Sibutramine—SLC6A3—Dopaminergic Neurogenesis—STAT3—liver cancer	0.000644	0.00583	CbGpPWpGaD
Sibutramine—Malaise—Epirubicin—liver cancer	0.000642	0.000722	CcSEcCtD
Sibutramine—Nervousness—Doxorubicin—liver cancer	0.00064	0.000719	CcSEcCtD
Sibutramine—Vertigo—Epirubicin—liver cancer	0.00064	0.000719	CcSEcCtD
Sibutramine—CYP3A4—Estrogen metabolism—CYP1A1—liver cancer	0.000639	0.00579	CbGpPWpGaD
Sibutramine—Syncope—Epirubicin—liver cancer	0.000638	0.000718	CcSEcCtD
Sibutramine—Leukopenia—Epirubicin—liver cancer	0.000637	0.000716	CcSEcCtD
Sibutramine—Back pain—Doxorubicin—liver cancer	0.000637	0.000716	CcSEcCtD
Sibutramine—SLC6A3—Parkinsons Disease Pathway—CASP3—liver cancer	0.000634	0.00574	CbGpPWpGaD
Sibutramine—Muscle spasms—Doxorubicin—liver cancer	0.000633	0.000712	CcSEcCtD
Sibutramine—Palpitations—Epirubicin—liver cancer	0.000629	0.000707	CcSEcCtD
Sibutramine—Loss of consciousness—Epirubicin—liver cancer	0.000626	0.000703	CcSEcCtD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.000624	0.00564	CbGpPWpGaD
Sibutramine—Cough—Epirubicin—liver cancer	0.000621	0.000698	CcSEcCtD
Sibutramine—Vision blurred—Doxorubicin—liver cancer	0.000621	0.000698	CcSEcCtD
Sibutramine—SLC6A3—Neuronal System—GLUL—liver cancer	0.000617	0.00559	CbGpPWpGaD
Sibutramine—Convulsion—Epirubicin—liver cancer	0.000617	0.000693	CcSEcCtD
Sibutramine—Hypertension—Epirubicin—liver cancer	0.000615	0.000691	CcSEcCtD
Sibutramine—CYP3A4—Irinotecan Pathway—APC—liver cancer	0.000612	0.00554	CbGpPWpGaD
Sibutramine—Ill-defined disorder—Doxorubicin—liver cancer	0.000611	0.000687	CcSEcCtD
Sibutramine—Anaemia—Doxorubicin—liver cancer	0.000609	0.000684	CcSEcCtD
Sibutramine—Arthralgia—Epirubicin—liver cancer	0.000606	0.000681	CcSEcCtD
Sibutramine—Myalgia—Epirubicin—liver cancer	0.000606	0.000681	CcSEcCtD
Sibutramine—Chest pain—Epirubicin—liver cancer	0.000606	0.000681	CcSEcCtD
Sibutramine—Agitation—Doxorubicin—liver cancer	0.000605	0.00068	CcSEcCtD
Sibutramine—Anxiety—Epirubicin—liver cancer	0.000604	0.000679	CcSEcCtD
Sibutramine—Discomfort—Epirubicin—liver cancer	0.000599	0.000673	CcSEcCtD
Sibutramine—SLC6A2—Monoamine Transport—TNF—liver cancer	0.000597	0.00541	CbGpPWpGaD
Sibutramine—SLC6A3—Dopaminergic Neurogenesis—TGFB1—liver cancer	0.000597	0.0054	CbGpPWpGaD
Sibutramine—Malaise—Doxorubicin—liver cancer	0.000594	0.000668	CcSEcCtD
Sibutramine—Dry mouth—Epirubicin—liver cancer	0.000593	0.000666	CcSEcCtD
Sibutramine—Vertigo—Doxorubicin—liver cancer	0.000592	0.000665	CcSEcCtD
Sibutramine—Syncope—Doxorubicin—liver cancer	0.000591	0.000664	CcSEcCtD
Sibutramine—Leukopenia—Doxorubicin—liver cancer	0.00059	0.000663	CcSEcCtD
Sibutramine—SLC6A4—NRF2 pathway—GSTP1—liver cancer	0.00059	0.00534	CbGpPWpGaD
Sibutramine—CYP3A4—Xenobiotics—CYP1A1—liver cancer	0.000588	0.00532	CbGpPWpGaD
Sibutramine—Confusional state—Epirubicin—liver cancer	0.000586	0.000659	CcSEcCtD
Sibutramine—Palpitations—Doxorubicin—liver cancer	0.000582	0.000654	CcSEcCtD
Sibutramine—SLC6A4—NRF2 pathway—HMOX1—liver cancer	0.000581	0.00526	CbGpPWpGaD
Sibutramine—Anaphylactic shock—Epirubicin—liver cancer	0.000581	0.000653	CcSEcCtD
Sibutramine—Oedema—Epirubicin—liver cancer	0.000581	0.000653	CcSEcCtD
Sibutramine—Loss of consciousness—Doxorubicin—liver cancer	0.000579	0.000651	CcSEcCtD
Sibutramine—Infection—Epirubicin—liver cancer	0.000577	0.000649	CcSEcCtD
Sibutramine—Cough—Doxorubicin—liver cancer	0.000575	0.000646	CcSEcCtD
Sibutramine—Shock—Epirubicin—liver cancer	0.000572	0.000643	CcSEcCtD
Sibutramine—Convulsion—Doxorubicin—liver cancer	0.000571	0.000642	CcSEcCtD
Sibutramine—Thrombocytopenia—Epirubicin—liver cancer	0.000569	0.000639	CcSEcCtD
Sibutramine—Hypertension—Doxorubicin—liver cancer	0.000569	0.000639	CcSEcCtD
Sibutramine—Tachycardia—Epirubicin—liver cancer	0.000567	0.000637	CcSEcCtD
Sibutramine—CYP3A4—Tamoxifen metabolism—CYP1A1—liver cancer	0.000565	0.00512	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—GGT1—liver cancer	0.000564	0.00511	CbGpPWpGaD
Sibutramine—Skin disorder—Epirubicin—liver cancer	0.000564	0.000634	CcSEcCtD
Sibutramine—Hyperhidrosis—Epirubicin—liver cancer	0.000562	0.000631	CcSEcCtD
Sibutramine—Arthralgia—Doxorubicin—liver cancer	0.000561	0.00063	CcSEcCtD
Sibutramine—Myalgia—Doxorubicin—liver cancer	0.000561	0.00063	CcSEcCtD
Sibutramine—Chest pain—Doxorubicin—liver cancer	0.000561	0.00063	CcSEcCtD
Sibutramine—Anxiety—Doxorubicin—liver cancer	0.000559	0.000628	CcSEcCtD
Sibutramine—Discomfort—Doxorubicin—liver cancer	0.000554	0.000623	CcSEcCtD
Sibutramine—Anorexia—Epirubicin—liver cancer	0.000554	0.000623	CcSEcCtD
Sibutramine—Dry mouth—Doxorubicin—liver cancer	0.000548	0.000617	CcSEcCtD
Sibutramine—Hypotension—Epirubicin—liver cancer	0.000543	0.00061	CcSEcCtD
Sibutramine—Confusional state—Doxorubicin—liver cancer	0.000542	0.000609	CcSEcCtD
Sibutramine—SLC6A4—NRF2 pathway—GSTM1—liver cancer	0.000542	0.0049	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—HGF—liver cancer	0.000542	0.0049	CbGpPWpGaD
Sibutramine—Anaphylactic shock—Doxorubicin—liver cancer	0.000538	0.000604	CcSEcCtD
Sibutramine—Oedema—Doxorubicin—liver cancer	0.000538	0.000604	CcSEcCtD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.000535	0.00484	CbGpPWpGaD
Sibutramine—Infection—Doxorubicin—liver cancer	0.000534	0.0006	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000529	0.000595	CcSEcCtD
Sibutramine—SLC6A3—Monoamine Transport—TNF—liver cancer	0.000529	0.00479	CbGpPWpGaD
Sibutramine—Shock—Doxorubicin—liver cancer	0.000529	0.000595	CcSEcCtD
Sibutramine—Thrombocytopenia—Doxorubicin—liver cancer	0.000526	0.000592	CcSEcCtD
Sibutramine—Insomnia—Epirubicin—liver cancer	0.000525	0.000591	CcSEcCtD
Sibutramine—Tachycardia—Doxorubicin—liver cancer	0.000525	0.00059	CcSEcCtD
Sibutramine—Skin disorder—Doxorubicin—liver cancer	0.000522	0.000587	CcSEcCtD
Sibutramine—Paraesthesia—Epirubicin—liver cancer	0.000522	0.000586	CcSEcCtD
Sibutramine—Hyperhidrosis—Doxorubicin—liver cancer	0.00052	0.000584	CcSEcCtD
Sibutramine—Dyspnoea—Epirubicin—liver cancer	0.000518	0.000582	CcSEcCtD
Sibutramine—Somnolence—Epirubicin—liver cancer	0.000516	0.000581	CcSEcCtD
Sibutramine—Anorexia—Doxorubicin—liver cancer	0.000512	0.000576	CcSEcCtD
Sibutramine—Dyspepsia—Epirubicin—liver cancer	0.000511	0.000575	CcSEcCtD
Sibutramine—SLC6A2—NRF2 pathway—GSTP1—liver cancer	0.000507	0.00459	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.000505	0.00458	CbGpPWpGaD
Sibutramine—Decreased appetite—Epirubicin—liver cancer	0.000505	0.000568	CcSEcCtD
Sibutramine—Hypotension—Doxorubicin—liver cancer	0.000502	0.000565	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Epirubicin—liver cancer	0.000502	0.000564	CcSEcCtD
Sibutramine—SLC6A2—NRF2 pathway—HMOX1—liver cancer	0.0005	0.00453	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—GGT1—liver cancer	0.0005	0.00453	CbGpPWpGaD
Sibutramine—Pain—Epirubicin—liver cancer	0.000497	0.000558	CcSEcCtD
Sibutramine—Constipation—Epirubicin—liver cancer	0.000497	0.000558	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00049	0.000551	CcSEcCtD
Sibutramine—Insomnia—Doxorubicin—liver cancer	0.000486	0.000547	CcSEcCtD
Sibutramine—Paraesthesia—Doxorubicin—liver cancer	0.000483	0.000543	CcSEcCtD
Sibutramine—Dyspnoea—Doxorubicin—liver cancer	0.000479	0.000539	CcSEcCtD
Sibutramine—Feeling abnormal—Epirubicin—liver cancer	0.000479	0.000538	CcSEcCtD
Sibutramine—Somnolence—Doxorubicin—liver cancer	0.000478	0.000537	CcSEcCtD
Sibutramine—Gastrointestinal pain—Epirubicin—liver cancer	0.000475	0.000534	CcSEcCtD
Sibutramine—Dyspepsia—Doxorubicin—liver cancer	0.000473	0.000532	CcSEcCtD
Sibutramine—Decreased appetite—Doxorubicin—liver cancer	0.000467	0.000525	CcSEcCtD
Sibutramine—SLC6A2—NRF2 pathway—GSTM1—liver cancer	0.000466	0.00422	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—HGF—liver cancer	0.000466	0.00422	CbGpPWpGaD
Sibutramine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000464	0.000522	CcSEcCtD
Sibutramine—Urticaria—Epirubicin—liver cancer	0.000462	0.000519	CcSEcCtD
Sibutramine—Pain—Doxorubicin—liver cancer	0.00046	0.000517	CcSEcCtD
Sibutramine—Constipation—Doxorubicin—liver cancer	0.00046	0.000517	CcSEcCtD
Sibutramine—CYP3A4—Biological oxidations—UGDH—liver cancer	0.00046	0.00416	CbGpPWpGaD
Sibutramine—Abdominal pain—Epirubicin—liver cancer	0.000459	0.000516	CcSEcCtD
Sibutramine—Body temperature increased—Epirubicin—liver cancer	0.000459	0.000516	CcSEcCtD
Sibutramine—SLC6A3—NRF2 pathway—GSTP1—liver cancer	0.000449	0.00407	CbGpPWpGaD
Sibutramine—Feeling abnormal—Doxorubicin—liver cancer	0.000443	0.000498	CcSEcCtD
Sibutramine—SLC6A3—NRF2 pathway—HMOX1—liver cancer	0.000443	0.00401	CbGpPWpGaD
Sibutramine—Gastrointestinal pain—Doxorubicin—liver cancer	0.00044	0.000494	CcSEcCtD
Sibutramine—Hypersensitivity—Epirubicin—liver cancer	0.000428	0.000481	CcSEcCtD
Sibutramine—Urticaria—Doxorubicin—liver cancer	0.000427	0.00048	CcSEcCtD
Sibutramine—Abdominal pain—Doxorubicin—liver cancer	0.000425	0.000478	CcSEcCtD
Sibutramine—Body temperature increased—Doxorubicin—liver cancer	0.000425	0.000478	CcSEcCtD
Sibutramine—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.00042	0.0038	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000418	0.00378	CbGpPWpGaD
Sibutramine—Asthenia—Epirubicin—liver cancer	0.000417	0.000469	CcSEcCtD
Sibutramine—SLC6A3—NRF2 pathway—HGF—liver cancer	0.000413	0.00374	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—GSTM1—liver cancer	0.000413	0.00374	CbGpPWpGaD
Sibutramine—Pruritus—Epirubicin—liver cancer	0.000411	0.000462	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000399	0.00361	CbGpPWpGaD
Sibutramine—Diarrhoea—Epirubicin—liver cancer	0.000397	0.000447	CcSEcCtD
Sibutramine—Hypersensitivity—Doxorubicin—liver cancer	0.000396	0.000445	CcSEcCtD
Sibutramine—Asthenia—Doxorubicin—liver cancer	0.000386	0.000434	CcSEcCtD
Sibutramine—Dizziness—Epirubicin—liver cancer	0.000384	0.000432	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000382	0.00346	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000382	0.00346	CbGpPWpGaD
Sibutramine—Pruritus—Doxorubicin—liver cancer	0.00038	0.000428	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.00037	0.00335	CbGpPWpGaD
Sibutramine—Vomiting—Epirubicin—liver cancer	0.000369	0.000415	CcSEcCtD
Sibutramine—Diarrhoea—Doxorubicin—liver cancer	0.000368	0.000413	CcSEcCtD
Sibutramine—Rash—Epirubicin—liver cancer	0.000366	0.000412	CcSEcCtD
Sibutramine—Dermatitis—Epirubicin—liver cancer	0.000366	0.000411	CcSEcCtD
Sibutramine—Headache—Epirubicin—liver cancer	0.000364	0.000409	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—PPARA—liver cancer	0.000364	0.00329	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000361	0.00327	CbGpPWpGaD
Sibutramine—Dizziness—Doxorubicin—liver cancer	0.000355	0.0004	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000353	0.0032	CbGpPWpGaD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000352	0.00318	CbGpPWpGaD
Sibutramine—Nausea—Epirubicin—liver cancer	0.000345	0.000388	CcSEcCtD
Sibutramine—Vomiting—Doxorubicin—liver cancer	0.000342	0.000384	CcSEcCtD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.00034	0.00307	CbGpPWpGaD
Sibutramine—Rash—Doxorubicin—liver cancer	0.000339	0.000381	CcSEcCtD
Sibutramine—Dermatitis—Doxorubicin—liver cancer	0.000339	0.000381	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000339	0.00306	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000339	0.00306	CbGpPWpGaD
Sibutramine—Headache—Doxorubicin—liver cancer	0.000337	0.000379	CcSEcCtD
Sibutramine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000335	0.00303	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—NR1H4—liver cancer	0.00032	0.0029	CbGpPWpGaD
Sibutramine—Nausea—Doxorubicin—liver cancer	0.000319	0.000359	CcSEcCtD
Sibutramine—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000302	0.00273	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—PPARG—liver cancer	0.000301	0.00272	CbGpPWpGaD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000291	0.00263	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000275	0.00249	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—SERPINE1—liver cancer	0.000271	0.00245	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CASP3—liver cancer	0.000269	0.00243	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000269	0.00243	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000264	0.00239	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—JUN—liver cancer	0.000261	0.00236	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.00026	0.00236	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.000259	0.00235	CbGpPWpGaD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000244	0.00221	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000241	0.00219	CbGpPWpGaD
Sibutramine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000241	0.00218	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000238	0.00216	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000235	0.00213	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.000228	0.00207	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000227	0.00205	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000224	0.00203	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—BRAF—liver cancer	0.000224	0.00203	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000221	0.002	CbGpPWpGaD
Sibutramine—SLC6A4—NRF2 pathway—TGFB1—liver cancer	0.000221	0.002	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—JUN—liver cancer	0.000213	0.00193	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—MAPK8—liver cancer	0.000202	0.00183	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000198	0.00179	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—TNF—liver cancer	0.000196	0.00177	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—TGFB1—liver cancer	0.00019	0.00172	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—ALB—liver cancer	0.000189	0.00171	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000188	0.0017	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—RAF1—liver cancer	0.000187	0.00169	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—CYCS—liver cancer	0.000184	0.00167	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000179	0.00162	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—BRAF—liver cancer	0.000172	0.00155	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—TGFB1—liver cancer	0.000168	0.00152	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—ALB—liver cancer	0.000168	0.00152	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—CYCS—liver cancer	0.000163	0.00148	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.00016	0.00145	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL6—liver cancer	0.000158	0.00143	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000146	0.00132	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000144	0.00131	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—RAF1—liver cancer	0.000143	0.0013	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000142	0.00128	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—TP53—liver cancer	0.000141	0.00127	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000134	0.00122	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—PPARA—liver cancer	0.000129	0.00117	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—IL6—liver cancer	0.000129	0.00117	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000121	0.00109	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000119	0.00108	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—PPARA—liver cancer	0.000115	0.00104	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000111	0.001	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000109	0.00099	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000105	0.000951	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000104	0.000938	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—HRAS—liver cancer	0.000103	0.000932	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ALB—liver cancer	9.61e-05	0.00087	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—RAF1—liver cancer	8.69e-05	0.000787	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ALB—liver cancer	8.52e-05	0.000771	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—HRAS—liver cancer	7.89e-05	0.000714	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—UGDH—liver cancer	7.86e-05	0.000711	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—RAF1—liver cancer	7.7e-05	0.000697	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—EPT1—liver cancer	7.39e-05	0.000669	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—TAT—liver cancer	7.01e-05	0.000634	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CPT1B—liver cancer	4.76e-05	0.000431	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GLUL—liver cancer	4.76e-05	0.000431	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NR1H4—liver cancer	4.59e-05	0.000416	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTA3—liver cancer	4.51e-05	0.000409	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTA4—liver cancer	4.13e-05	0.000374	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTA2—liver cancer	4.02e-05	0.000364	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTA1—liver cancer	3.88e-05	0.000351	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NAT2—liver cancer	3.84e-05	0.000347	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ALDOB—liver cancer	3.68e-05	0.000333	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CRABP1—liver cancer	3.51e-05	0.000318	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HPGDS—liver cancer	3.07e-05	0.000278	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PSMA4—liver cancer	2.74e-05	0.000248	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PSMD10—liver cancer	2.74e-05	0.000248	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GOT2—liver cancer	2.66e-05	0.000241	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYP2E1—liver cancer	2.5e-05	0.000226	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYCS—liver cancer	2.34e-05	0.000212	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GGT1—liver cancer	2.3e-05	0.000208	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GOT1—liver cancer	2.3e-05	0.000208	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTP1—liver cancer	2.06e-05	0.000187	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HMOX1—liver cancer	2.03e-05	0.000184	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GSTM1—liver cancer	1.9e-05	0.000172	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYP1A1—liver cancer	1.8e-05	0.000163	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—MTHFR—liver cancer	1.68e-05	0.000152	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PPARA—liver cancer	1.64e-05	0.000149	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3CG—liver cancer	1.41e-05	0.000127	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PPARG—liver cancer	1.36e-05	0.000123	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3CD—liver cancer	1.24e-05	0.000112	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ALB—liver cancer	1.22e-05	0.000111	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3CB—liver cancer	1.08e-05	9.76e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3CA—liver cancer	6.58e-06	5.95e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—AKT1—liver cancer	5.37e-06	4.86e-05	CbGpPWpGaD
